Atlas Trials

Study on the Efficacy, Safety, and Tolerability of Cariprazine Relative to Placebo in Participants With Bipolar I Depression

Clinical trial NCT02670551 · COMPLETED

Trial details

NCT number
NCT02670551
Sponsor
Forest Laboratories
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Bipolar DisorderDepression
Start date
2016-03-17
Primary completion
2017-07-19
Enrollment
488

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.